Correction to: Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy (Molecular Imaging and Biology, (2018), 10.1007/s11307-018-1252-5)

Rudolf A. Werner; Harun Ilhan; Sebastian Lehner; László Papp; Norbert Zsótér; Imke Schatka; Dirk O. Muegge; Mehrbod S. Javadi; Takahiro Higuchi; Andreas K. Buck; Peter Bartenstein; Frank Bengel; Markus Essler; Constantin Lapa; Ralph A. Bundschuh

doi:10.1007/s11307-018-1261-4

Correction to: Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy (Molecular Imaging and Biology, (2018), 10.1007/s11307-018-1252-5)

Rudolf A. Werner, Harun Ilhan, Sebastian Lehner, László Papp, Norbert Zsótér, Imke Schatka, Dirk O. Muegge, Mehrbod S. Javadi, Takahiro Higuchi, Andreas K. Buck, Peter Bartenstein, Frank Bengel, Markus Essler, Constantin Lapa, Ralph A. Bundschuh

Research output: Contribution to journal › Comment/debate › peer-review

1 Citation (Scopus)

Abstract

The article “Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy,” was originally published electronically on the publisher’s internet portal without open access.

Original language	English
Pages (from-to)	1068
Number of pages	1
Journal	Molecular Imaging and Biology
Volume	20
Issue number	6
DOIs	https://doi.org/10.1007/s11307-018-1261-4
Publication status	Published - Dec 1 2018
Externally published	Yes

ASJC Scopus subject areas

Oncology
Radiology Nuclear Medicine and imaging
Cancer Research

Access to Document

10.1007/s11307-018-1261-4

Fingerprint Dive into the research topics of 'Correction to: Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy (Molecular Imaging and Biology, (2018), 10.1007/s11307-018-1252-5)'. Together they form a unique fingerprint.

Cite this

Werner, R. A., Ilhan, H., Lehner, S., Papp, L., Zsótér, N., Schatka, I., Muegge, D. O., Javadi, M. S., Higuchi, T., Buck, A. K., Bartenstein, P., Bengel, F., Essler, M., Lapa, C., & Bundschuh, R. A. (2018). Correction to: Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy (Molecular Imaging and Biology, (2018), 10.1007/s11307-018-1252-5). Molecular Imaging and Biology, 20(6), 1068. https://doi.org/10.1007/s11307-018-1261-4

Correction to : Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy (Molecular Imaging and Biology, (2018), 10.1007/s11307-018-1252-5). / Werner, Rudolf A.; Ilhan, Harun; Lehner, Sebastian; Papp, László; Zsótér, Norbert; Schatka, Imke; Muegge, Dirk O.; Javadi, Mehrbod S.; Higuchi, Takahiro; Buck, Andreas K.; Bartenstein, Peter; Bengel, Frank; Essler, Markus; Lapa, Constantin; Bundschuh, Ralph A.

In: Molecular Imaging and Biology, Vol. 20, No. 6, 01.12.2018, p. 1068.

Research output: Contribution to journal › Comment/debate › peer-review

Werner, RA, Ilhan, H, Lehner, S, Papp, L, Zsótér, N, Schatka, I, Muegge, DO, Javadi, MS, Higuchi, T, Buck, AK, Bartenstein, P, Bengel, F, Essler, M, Lapa, C & Bundschuh, RA 2018, 'Correction to: Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy (Molecular Imaging and Biology, (2018), 10.1007/s11307-018-1252-5)', Molecular Imaging and Biology, vol. 20, no. 6, pp. 1068. https://doi.org/10.1007/s11307-018-1261-4

Werner RA, Ilhan H, Lehner S, Papp L, Zsótér N, Schatka I et al. Correction to: Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy (Molecular Imaging and Biology, (2018), 10.1007/s11307-018-1252-5). Molecular Imaging and Biology. 2018 Dec 1;20(6):1068. https://doi.org/10.1007/s11307-018-1261-4

Werner, Rudolf A. ; Ilhan, Harun ; Lehner, Sebastian ; Papp, László ; Zsótér, Norbert ; Schatka, Imke ; Muegge, Dirk O. ; Javadi, Mehrbod S. ; Higuchi, Takahiro ; Buck, Andreas K. ; Bartenstein, Peter ; Bengel, Frank ; Essler, Markus ; Lapa, Constantin ; Bundschuh, Ralph A. / Correction to : Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy (Molecular Imaging and Biology, (2018), 10.1007/s11307-018-1252-5). In: Molecular Imaging and Biology. 2018 ; Vol. 20, No. 6. pp. 1068.

@article{4b4470afd8b0464e8e8cfdbe99a2eb5b,

title = "Correction to: Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy (Molecular Imaging and Biology, (2018), 10.1007/s11307-018-1252-5)",

abstract = "The article “Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy,” was originally published electronically on the publisher{\textquoteright}s internet portal without open access.",

author = "Werner, {Rudolf A.} and Harun Ilhan and Sebastian Lehner and L{\'a}szl{\'o} Papp and Norbert Zs{\'o}t{\'e}r and Imke Schatka and Muegge, {Dirk O.} and Javadi, {Mehrbod S.} and Takahiro Higuchi and Buck, {Andreas K.} and Peter Bartenstein and Frank Bengel and Markus Essler and Constantin Lapa and Bundschuh, {Ralph A.}",

year = "2018",

month = dec,

day = "1",

doi = "10.1007/s11307-018-1261-4",

language = "English",

volume = "20",

pages = "1068",

journal = "Molecular Imaging and Biology",

issn = "1536-1632",

publisher = "Springer New York",

number = "6",

}

TY - JOUR

T1 - Correction to

T2 - Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy (Molecular Imaging and Biology, (2018), 10.1007/s11307-018-1252-5)

AU - Werner, Rudolf A.

AU - Ilhan, Harun

AU - Lehner, Sebastian

AU - Papp, László

AU - Zsótér, Norbert

AU - Schatka, Imke

AU - Muegge, Dirk O.

AU - Javadi, Mehrbod S.

AU - Higuchi, Takahiro

AU - Buck, Andreas K.

AU - Bartenstein, Peter

AU - Bengel, Frank

AU - Essler, Markus

AU - Lapa, Constantin

AU - Bundschuh, Ralph A.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - The article “Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy,” was originally published electronically on the publisher’s internet portal without open access.

AB - The article “Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy,” was originally published electronically on the publisher’s internet portal without open access.

UR - http://www.scopus.com/inward/record.url?scp=85051437754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051437754&partnerID=8YFLogxK

U2 - 10.1007/s11307-018-1261-4

DO - 10.1007/s11307-018-1261-4

M3 - Comment/debate

C2 - 30109540

AN - SCOPUS:85051437754

VL - 20

SP - 1068

JO - Molecular Imaging and Biology

JF - Molecular Imaging and Biology

SN - 1536-1632

IS - 6

ER -

Correction to: Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy (Molecular Imaging and Biology, (2018), 10.1007/s11307-018-1252-5)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this